Gilead Sciences (GILD)

$111.53 0.00 (0.00%)

16:00 EST GILD Stock Quote Delayed 30 Minutes

Hidden Gems: 7 Oversold Stocks Ready for a Major Rebound

By Josh Enomoto, InvestorPlace Contributor Mar 4, 2024

Ordinarily, you’ll want to avoid excessively red-stained ideas. Although certain exceptions might be made for these oversold stocks ready for rebound. Certain relevant enterprises may…

Stock Alert: 3 Market Giants on the Brink of Monumental Rallies

From Zero to Hero: 7 Stock Losers That Could Turn Things Around in 2024

7 Contrarian Biotech Stocks to Consider Amid Sector Weakness

Volume:

Previous Close -

Market Cap 139.84B

PE Ratio 1,394.13

EPS 0.08

Volume (Avg. Vol.) 1,025

Day's Range -

52-Week Range $62.07 - $112.11

Dividend & Yield $3.08 (2.76%)

GILD Stock Predictions, Articles, and Gilead Sciences News

7 Biotech Stocks Fighting America’s Deadliest Diseases

By Josh Enomoto, InvestorPlace Contributor Feb 8, 2024

Unlike many other market segments, biotech stocks stand out for their direct relevance. For example, investors who typically wager on aerospace and defense plays usually…

3 Top Pharma Stocks to Buy Now: February 2024

By Rick Orford, InvestorPlace Contributor Feb 1, 2024

Take a look at why these three buy-rated pharma stocks could be your ticket to explosive portfolio growth.

Gilead’s Quiet Revolution: Is GILD the Next Big Stock to Soar?

By David Moadel, InvestorPlace Contributor Jan 10, 2024

While Wall Street obsesses over weight-loss drugs, Gilead Sciences is working on life-saving treatments and GILD stock looks ready to rally.

Nasdaq 100 Alert: 7 Undervalued Tech Stocks Ready to Rocket in 2024

By Rich Duprey, InvestorPlace Contributor Jan 3, 2024

The Nasdaq 100 had a banner year. After a disastrous 2022 that saw the tech-laden index lose one-third of its value, it rebounded sharply in…

3 Biotech Stocks to Buy in the TradeSmith ‘Green Zone’

By TradeSmith Research Staff Dec 21, 2023

It's now time to take a look at these three biotech stocks to buy, as each one is currently within TradeSmith's "Green Zone."

Why Is Hookipa Pharma (HOOK) Stock Up 81% Today?

By William White, InvestorPlace Writer Dec 21, 2023

Hookipa Pharma stock is rising higher on Thursday as investors react to a purchase agreement for 15 million shares of HOOK.

Why Is Compugen (CGEN) Stock Up 189% Today?

By William White, InvestorPlace Writer Dec 19, 2023

Compugen stock is up on Tuesday as investors in CGEN shares react to an exclusive licensing agreement with Gilead Sciences.

Next-Gen Biotech: 3 Companies Leading the Charge in Gene Therapy

By Larry Ramer, InvestorPlace Contributor Dec 7, 2023

These three gene therapy stocks should get huge boosts over the long term from the use of gene editing techniques to treat diseases.

7 Healthcare Stocks to invest in for a Healthy Future

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor Oct 20, 2023

Healthcare stocks may be one of the few winning sectors considering today's economic uncertainty and market turns. Here are the winners.

Why Is Assembly Biosciences (ASMB) Stock Up 92% Today?

By William White, InvestorPlace Writer Oct 17, 2023

Assembly Biosciences stock is taking off with heavy trading of ASMB shares after the company announced a new collaboration agreement!

Cancer Drug Approval? 3 Biotech Stocks on the Brink of Breakthroughs

By Larry Ramer, InvestorPlace Contributor Oct 2, 2023

CAR T therapies have major advantages over traditional cancer drugs. Here are three of the best cancer drug stocks set to benefit from CAR T.

GILD Stock Alert: FDA Expands Indications for Gilead Sciences’ Veklury Covid-19 Treatment

By William White, InvestorPlace Writer Aug 24, 2023

Gilead Sciences (GILD) stock is on the move Thursday following additional FDA approval for its Veklury Covid-19 treatment.

The 3 Best Biotech Stocks to Buy in August

By Jeremy Flint, InvestorPlace Contributor Aug 9, 2023

Even as healthcare stocks suffer from post-pandemic fatigue, these three of the best biotech stocks to buy and ride the wave of good news.

Buy Alert: 3 Biotech Stocks Nearing Super Attractive Entry Points

By Joel Baglole, InvestorPlace Contributor Aug 1, 2023

Investors looking to give their portfolio a boost should consider one of these leading biotech names, which are undervalued right now.

The 7 Most Undervalued Nasdaq Stocks to Buy Now: July 2023

By Ian Bezek, InvestorPlace Contributor Jul 19, 2023

The market is soaring, but there is still time to buy these seven undervalued Nasdaq stocks before they head higher.

The 3 Best Biotech Stocks to Buy In July

By Joel Baglole, InvestorPlace Contributor Jul 5, 2023

With these companies fueling sales and earnings with medical innovations and breakthroughs, they may be the best biotech stocks to pick up.

How to Retire Rich: Biotech Stocks Edition

By Josh Enomoto, InvestorPlace Contributor Jun 18, 2023

Thanks to its enormous and practically permanent relevancies, the biotech sector offers a great avenue for retirement planning stocks.

3 Biotech Stocks That Could Skyrocket in the Next 12 Months

By Muslim Farooque, InvestorPlace Contributor Jun 7, 2023

These promising biotech stocks are risky but offer tremendous upside generating stellar long-term returns in the upcoming 12 months.

3 Undervalued Biotech Stocks to Buy Before They Blast Off

By Chris Markoch, InvestorPlace Contributor Jun 2, 2023

Fundamental analysis makes these three undervalued biotech stocks to buy plus they have other catalysts that make them compelling.

3 Analyst Upgrades That Smart Investors Won’t Ignore

By Chris Markoch, InvestorPlace Contributor May 17, 2023

Even the most experienced investors have only so many hours in the day to perform their due diligence. That’s where analyst ratings can be helpful.…

Gilead Sciences (GILD)

Hidden Gems: 7 Oversold Stocks Ready for a Major Rebound

Stock Alert: 3 Market Giants on the Brink of Monumental Rallies

From Zero to Hero: 7 Stock Losers That Could Turn Things Around in 2024

7 Contrarian Biotech Stocks to Consider Amid Sector Weakness

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Gilead Sciences (GILD)

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

GILD Stock Predictions, Articles, and Gilead Sciences News

Subscriber Sign in